KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash & Current Investments (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Cash & Current Investments readings, the most recent being $3.3 billion for Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 45.25% to $3.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.3 billion, a 45.25% decrease, with the full-year FY2025 number at $10.1 billion, up 81.42% from a year prior.
  • Cash & Current Investments hit $3.3 billion in Q1 2026 for Thermo Fisher Scientific, down from $10.1 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $10.1 billion in Q4 2025 to a low of $1.9 billion in Q3 2022.
  • Median Cash & Current Investments over the past 5 years was $5.9 billion (2025), compared with a mean of $5.6 billion.
  • Biggest five-year swings in Cash & Current Investments: tumbled 75.73% in 2022 and later surged 181.62% in 2024.
  • Thermo Fisher Scientific's Cash & Current Investments stood at $8.5 billion in 2022, then dropped by 5.21% to $8.1 billion in 2023, then crashed by 31.06% to $5.6 billion in 2024, then skyrocketed by 81.42% to $10.1 billion in 2025, then plummeted by 67.78% to $3.3 billion in 2026.
  • The last three reported values for Cash & Current Investments were $3.3 billion (Q1 2026), $10.1 billion (Q4 2025), and $3.5 billion (Q3 2025) per Business Quant data.